Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Frontier Smart Technologies Grp Ltd

8 Jul 2019 07:00

RNS Number : 7136E
Science Group PLC
08 July 2019
 

 

8 July 2019

Science Group plc

(the "Company")

Investment in Frontier Smart Technologies Group Limited

("Frontier")

 

 

Science Group plc (AIM:SAG) welcomes the Frontier announcement issued on Friday 5 July regarding the clarification of the Frontier statement issued on 14 June 2019. Science Group concludes that:

· Science Group's Offer is the only offer for Frontier - as announced on 1 July and posted to Frontier Shareholders on 2 July 2019;

· Contrary to previous indications by Frontier (14 June) regarding the alternative approach, it is now "unlikely that the discussions will result in an offer for" Frontier from this alternative source;

· Frontier's discussions regarding a further alternative new proposal from the same party are at no more than a "concept" stage, after 3 weeks of "urgently seeking to clarify" this alternative approach. The basic transaction framework has not even been agreed and "there is no meaningful prospect of agreeing Heads of Terms, less still entering into a definitive legal agreement, prior to the closing date of the Science Group Offer of 16 July 2019". This indicates that the "potential, but uncertain" discussions are preliminary and speculative; and

· Frontier's operating performance and expectations for the current year remain unchanged following the significant downgrade it announced on 9 May 2019, which resulted in Frontier's share price falling to a closing price of 13.4 pence.

 

In summary, despite the substantial premium being offered by Science Group relative to the share price on the date of the trading update, the Frontier Board are advising Frontier Shareholders to reject the Science Group Offer on the basis that at some undefined point in the future, Frontier may possibly agree a joint venture with an undefined party into which Frontier would transfer key assets. The structure and terms of this hypothetical activity are currently unknown to the Frontier Board and the potential value to be created and how any such value would be realised for Frontier Shareholders is completely unclear. Furthermore, even if this "potential, but uncertain, prospect" did develop, the Frontier Board may or may not grant Frontier Shareholders the opportunity to vote on this transfer of assets and the terms of any transaction.

 

Throughout the past 8 weeks, in the opinion of Science Group, Frontier has repeatedly taken actions which have had the effect of frustrating the proposed acquisition of Frontier by Science Group. This latest "concept" of a non-specific strategy being proposed by the Frontier Board can only be regarded similarly. It should be remembered that, at 31 December 2018, Frontier had net retained losses of $175.5 million resulting from Frontier's previous strategies and that between January 2018 and 9 May 2019, the current Frontier Board pursued a strategy that resulted in a share price decline of over 90%.

 

At the close of trading on 5 July 2019, Science Group held 11,879,601 shares, equivalent to 29.2% of the voting share capital of Frontier. Science Group reiterates its previous statements that it does not anticipate supporting any alternative "potential corporate transaction".

 

Science Group does not anticipate increasing the Offer price and reminds Frontier Shareholders that the Offer of 35 pence per share, represents:

· a 161.6% premium to the closing share price on 9 May 2019, the date of the Frontier trading update; and

· a 137.3% premium to the share price on 17 May 2019, the last trading day prior to the announcement of Science Group's approach.

 

Science Group also reminds Frontier Shareholders that the closing date for the Science Group Offer is Tuesday 16 July 2019. At the present time, and taking into account the Frontier announcement issued on 5 July, Science Group does not anticipate extending the Offer, nor the Panmure Gordon Trading Facility, but retains the option to do so if considered appropriate at the sole discretion of the Science Group Board

 

In conclusion, Science Group encourages Frontier Shareholders to accept the Science Group Offer, or sell their shares through the Panmure Gordon Trading Facility, as soon as possible and in any event prior to the closing date of Tuesday 16 July 2019.

 

- Ends -

 

For further information:

Science Group plc

Martyn Ratcliffe, Chairman

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

Panmure Gordon (UK) Limited

Dominic Morley / Alina Vaskina

(Corporate Finance)

Erik Anderson (Corporate Broking)

 

 

Tel: +44 (0) 20 7886 2500

MHP Communications (PR Adviser to Science Group)

Reg Hoare / Pete Lambie

 

Tel: +44 (0) 20 3128 8100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBRGDRSGGBGCR
Date   Source Headline
18th Sep 20157:00 amRNSBlock Listing Interim Review
19th Aug 20157:00 amRNSTotal Voting Rights
3rd Aug 20157:00 amRNSHalf year trading update
13th Jul 20157:00 amRNSSt James's University Hospital trial
10th Jun 20157:00 amRNSCo-development agreement with Google
3rd Jun 201511:16 amRNSBoard change
29th May 20158:00 amRNSTotal Voting Rights
28th May 201510:20 amRNSResult of AGM
28th May 20157:00 amRNSTrading update
30th Apr 20158:00 amRNSTotal Voting Rights
21st Apr 20157:01 amRNSQueen Elizabeth Hospital trials SensiumVitals
21st Apr 20157:00 amRNSFull year results
1st Apr 201510:00 amRNSNotice of Results
19th Mar 20158:00 amRNSBlocklisting Interim Review
3rd Mar 20157:00 amRNSNorth American Healthcare distribution
29th Jan 20157:00 amRNSTrading update
28th Jan 20158:00 amRNSToumaz Employee Long Term Incentive Plan
28th Nov 20148:00 amRNSTotal Voting Rights
25th Sep 20147:00 amRNSHalf Yearly Report
5th Sep 20147:00 amRNSFrontier Silicon launches new digital radio module
4th Sep 20142:00 pmRNSFrontier Silicon supply agreement with Philips
27th Aug 201410:00 amRNSNotice of Results
19th Aug 20148:00 amRNSIssue of Equity
1st Aug 20147:00 amRNSTrading update
31st Jul 20148:00 amRNSTotal Voting Rights
29th Jul 20147:00 amRNSSensium awarded Technology Strategy Board funding
30th Jun 20147:00 amRNSSouth African distribution for SensiumVitals
26th Jun 20148:00 amRNSEmployee Long Term Incentive Plan
23rd May 20144:34 pmRNSResult of AGM
23rd May 20147:00 amRNSTrading Update
20th May 20147:00 amRNSFrontier Silicon gains Digital Tick Mark approval
8th May 20147:00 amRNSMiddle East distribution for SensiumVitals®
28th Apr 201410:00 amRNSIssue of Equity
14th Apr 20147:00 amRNSNew radio chip and module preview
31st Mar 20147:00 amRNSFull year results
26th Mar 20147:00 amRNSSensiumVitals® expands distribution network
24th Mar 20147:00 amRNSPioneer selects Frontier Silicon's technology
7th Mar 20142:42 pmRNSNotice of Results
31st Jan 201410:00 amRNSTotal Voting Rights
17th Jan 20147:00 amRNSYear-end trading update
16th Dec 20137:00 amRNSFrontier Silicon extends Imagination partnership
25th Nov 201310:47 amRNSResult of EGM
25th Nov 20137:00 amRNSVenice module wins industry excellence award
13th Nov 20137:00 amRNSPatrick Hannon elected President of WorldDMB
7th Nov 20137:00 amRNSPlacing
15th Oct 20137:00 amRNSSensiumVitals: CE marking & UK hospital pilot
15th Oct 20137:00 amRNSDistribution agreement: first commercial US orders
23rd Sep 20137:00 amRNSHalf Year Results
9th Sep 20137:00 amRNSSpotify Connect Agreement
5th Sep 201311:20 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.